display:none
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
  • Webinars
  • Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis: A Public launch event

Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis: A Public launch event


Date/Time

September 8, 2022

Panelists

Matthew Diamond

Chief Medical Officer, Digital Health Center of Excellence, CDRH, FDA

Thorsten Vetter

Senior Scientific Officer, Scientific Advice Office, EMA

Moderator

Lucy Cesnakova

Program Lead at the Digital Medicine Society

Discussion Topic

For the first time ever, we have a blueprint for developing and deploying digital endpoints in medical product development. 

On Sept. 8, industry leaders Abbvie, Janssen, Novartis, Pfizer, UCB, Advancing Innovation in Dermatology, Almirall, GSK, Leo Pharma, Eli Lilly, and Sanofi collaborated to research the meaningfulness of nocturnal scratching to atopic dermatitis (AD) patients and developed new resources for deploying scratch digital measures in clinical trials.

In addition to addressing an unmet need for AD patients, this work lays the groundwork for advancing the use of digital endpoints in medical research and care. Event attendees learned about:

  • Results from a study on the meaningfulness of nocturnal scratch as a digital endpoint for AD patients
  • Best practices, definitions, and additional resources for understanding what good digital endpoint development and deployment look like
  • New tools that help you move beyond “what endpoints exist to measure?” to “I will use and measure this digital endpoint.”
  • What additional work is being done to advance the use of digital endpoints in medical research and care

DiMe’s own, Lucy Cenakova, moderated a panel with Matthew Diamond, Chief Medical Officer at FDA, and Thorsten Vetter, Senior Scientific Officer at EMA. 

Watch the video recording

Explore the Nocturnal Scratch resources

View the Nocturnal Scratch launch Webinar Slides

 

Sign up to receive our monthly updates


Engage with the dime community on slack


USING A DIME RESOURCE? Share your story


Contact Us


Copyright ©2023 The Digital Medicine Society (DiMe). All Rights Reserved.